dextran + cyclophosphamide

This term appears to denote a **non-specific combination or conjugate concept involving dextran and cyclophosphamide**, rather than a clearly identifiable named pharmaceutical product. Cyclophosphamide is a nitrogen mustard alkylating agent prodrug used in oncology and immunosuppression; dextran is a polysaccharide polymer commonly used as a carrier or excipient in drug-delivery systems. In the provided context, however, the cited publication does **not** describe dextran + cyclophosphamide; it discusses dextran conjugates of **cabazitaxel**, with CTX in that abstract referring to cabazitaxel rather than cyclophosphamide. Therefore, no specific validated dextran-cyclophosphamide drug product, branded combination, or well-defined clinical-stage asset can be confidently annotated from the supplied evidence alone.

Other names

dextran + cyclophosphamide